Login

Viorel Panait on the Evolution of Romanian-Ukrainian Collaboration and the Perspectives of Constanta Port | Panait Viorel - CEO of Comvex 00:10:00

Share On Facebook Share On Twitter

Panait Viorel is the CEO of Comvex Constanta.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
How Business News and Companies Affect Investments and Shares | Thys van Zyl, CEO, Everest Wealth Management, LLC.
00:10:00
What is Wealth Management? Insights from Kathy Carey, Director of Investment Research and Advanced Planning at Baird
00:10:00
Interview at VRIC with Tom Meyer, CEO of Archer | Tom Meyer, President, Chief Executive Officer and Director, Archer Exploration Corp. (IE)
00:10:00
Mary Burt-Godwin discusses social media safety tips for kids with Brad Rambur.
00:10:00
The Impact of Emotions and Cognitive Biases on Investment Decisions
00:10:00
Meri Grogan: Syverson Strege Team | Meri Grogan - Director of Finance & Administration of Syverson Strege
00:10:00
David Hampstead on Samarkand Group's Aquis Debut and £17M Fundraise | David Hampstead, CEO , Samarkand Global PLC.
00:10:00
Luis Cid Discusses Opdenergy's First Half Results and Future Growth Plans | Luis Cid , CEO ,Opdenergy holding SA.
00:10:00
invest and support founders from seed until the later stages|Adam Berger,Managing Director,Insight Partners
00:10:00
Impact Investing Before, During & After the Pandemic: A Webinar by IMPACTfolio and CoPeace | Julie McDaniel - PARTNER, FINANCIAL PLANNER of IMPACTfolio
00:10:00
Teleborsa S.p.A. interviews Alessio Aceti, CEO of Sababa Security.
00:10:00
Meeting Founders Before Theyre Founders|Alana Goyal,Founder and Managing Partner,base case capital

© 2017 - Neuhu+